These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
419 related articles for article (PubMed ID: 24373614)
1. Paracrine factors from mesenchymal stem cells: a proposed therapeutic tool for acute lung injury and acute respiratory distress syndrome. Li J; Huang S; Wu Y; Gu C; Gao D; Feng C; Wu X; Fu X Int Wound J; 2014 Apr; 11(2):114-21. PubMed ID: 24373614 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic implications of mesenchymal stem cells in acute lung injury/acute respiratory distress syndrome. Wang YY; Li XZ; Wang LB Stem Cell Res Ther; 2013 May; 4(3):45. PubMed ID: 23673003 [TBL] [Abstract][Full Text] [Related]
3. Concise review: Mesenchymal stem cells for acute lung injury: role of paracrine soluble factors. Lee JW; Fang X; Krasnodembskaya A; Howard JP; Matthay MA Stem Cells; 2011 Jun; 29(6):913-9. PubMed ID: 21506195 [TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cells overexpressing heme oxygenase-1 ameliorate lipopolysaccharide-induced acute lung injury in rats. Chen X; Wu S; Tang L; Ma L; Wang F; Feng H; Meng J; Han Z J Cell Physiol; 2019 May; 234(5):7301-7319. PubMed ID: 30362554 [TBL] [Abstract][Full Text] [Related]
5. Advances in the Regulation of Macrophage Polarization by Mesenchymal Stem Cells and Implications for ALI/ARDS Treatment. Liu C; Xiao K; Xie L Front Immunol; 2022; 13():928134. PubMed ID: 35880175 [TBL] [Abstract][Full Text] [Related]
6. Mesenchymal Stem Cell Therapy for ALI/ARDS: Therapeutic Potential and Challenges. Wang Z; Yu T; Hou Y; Zhou W; Ding Y; Nie H Curr Pharm Des; 2022; 28(27):2234-2240. PubMed ID: 35796453 [TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells induce dendritic cell immune tolerance via paracrine hepatocyte growth factor to alleviate acute lung injury. Lu Z; Chang W; Meng S; Xu X; Xie J; Guo F; Yang Y; Qiu H; Liu L Stem Cell Res Ther; 2019 Dec; 10(1):372. PubMed ID: 31801626 [TBL] [Abstract][Full Text] [Related]
8. Current understanding of the therapeutic benefits of mesenchymal stem cells in acute respiratory distress syndrome. Lopes-Pacheco M; Robba C; Rocco PRM; Pelosi P Cell Biol Toxicol; 2020 Feb; 36(1):83-102. PubMed ID: 31485828 [TBL] [Abstract][Full Text] [Related]
9. Stem cell conditioned medium improves acute lung injury in mice: in vivo evidence for stem cell paracrine action. Ionescu L; Byrne RN; van Haaften T; Vadivel A; Alphonse RS; Rey-Parra GJ; Weissmann G; Hall A; Eaton F; Thébaud B Am J Physiol Lung Cell Mol Physiol; 2012 Dec; 303(11):L967-77. PubMed ID: 23023971 [TBL] [Abstract][Full Text] [Related]
10. The efficacy of mesenchymal stromal cell-derived therapies for acute respiratory distress syndrome-a meta-analysis of preclinical trials. Wang F; Fang B; Qiang X; Shao J; Zhou L Respir Res; 2020 Nov; 21(1):307. PubMed ID: 33218340 [TBL] [Abstract][Full Text] [Related]
11. Emerging roles of mechanosensitive ion channels in acute lung injury/acute respiratory distress syndrome. Jia Q; Yang Y; Chen X; Yao S; Hu Z Respir Res; 2022 Dec; 23(1):366. PubMed ID: 36539808 [TBL] [Abstract][Full Text] [Related]
12. Genetically modified mesenchymal stem cell therapy for acute respiratory distress syndrome. Han J; Liu Y; Liu H; Li Y Stem Cell Res Ther; 2019 Dec; 10(1):386. PubMed ID: 31843004 [TBL] [Abstract][Full Text] [Related]
13. Mesenchymal Stromal Cells Attenuate Infection-Induced Acute Respiratory Distress Syndrome in Animal Experiments: A Meta-Analysis. Fengyun W; LiXin Z; Xinhua Q; Bin F Cell Transplant; 2020; 29():963689720969186. PubMed ID: 33164559 [TBL] [Abstract][Full Text] [Related]
14. Recent progress in mesenchymal stem cell-based therapy for acute lung injury. Liang J; Dai W; Xue S; Wu F; Cui E; Pan R Cell Tissue Bank; 2024 Jun; 25(2):677-684. PubMed ID: 38466563 [TBL] [Abstract][Full Text] [Related]
15. Activation of Wnt/β-catenin signalling promotes mesenchymal stem cells to repair injured alveolar epithelium induced by lipopolysaccharide in mice. Cai SX; Liu AR; Chen S; He HL; Chen QH; Xu JY; Pan C; Yang Y; Guo FM; Huang YZ; Liu L; Qiu HB Stem Cell Res Ther; 2015 Apr; 6(1):65. PubMed ID: 25889393 [TBL] [Abstract][Full Text] [Related]
16. Mesenchymal Stem Cell-Based Therapy as an Alternative to the Treatment of Acute Respiratory Distress Syndrome: Current Evidence and Future Perspectives. Fernández-Francos S; Eiro N; González-Galiano N; Vizoso FJ Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360616 [TBL] [Abstract][Full Text] [Related]
17. Mesenchymal Stromal Cells Modulate Macrophages in Clinically Relevant Lung Injury Models by Extracellular Vesicle Mitochondrial Transfer. Morrison TJ; Jackson MV; Cunningham EK; Kissenpfennig A; McAuley DF; O'Kane CM; Krasnodembskaya AD Am J Respir Crit Care Med; 2017 Nov; 196(10):1275-1286. PubMed ID: 28598224 [TBL] [Abstract][Full Text] [Related]
18. Extracellular vesicles in the pathogenesis and treatment of acute lung injury. Hu Q; Zhang S; Yang Y; Yao JQ; Tang WF; Lyon CJ; Hu TY; Wan MH Mil Med Res; 2022 Nov; 9(1):61. PubMed ID: 36316787 [TBL] [Abstract][Full Text] [Related]
19. Clinical review: Stem cell therapies for acute lung injury/acute respiratory distress syndrome - hope or hype? Hayes M; Curley G; Ansari B; Laffey JG Crit Care; 2012 Dec; 16(2):205. PubMed ID: 22424108 [TBL] [Abstract][Full Text] [Related]
20. Interplay between pulmonary epithelial stem cells and innate immune cells contribute to the repair and regeneration of ALI/ARDS. Wang J; Peng X; Yuan N; Wang B; Chen S; Wang B; Xie L Transl Res; 2024 Oct; 272():111-125. PubMed ID: 38897427 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]